EUROPEAN MARKETS FOR TRANSFUSION MANAGEMENT PRODUCTS

114 Pages | 28 Exhibits | 2009 Analysis | Forecasts Through 2013

OVERVIEW:
In Europe, approximately 2 million patients lose a sufficient amount of blood annually to require the transfusion of at least 1 unit of blood. Blood transfusions most often are required for cases of acute blood loss (e.g., surgery or trauma) or for cases in which the patient is receiving ongoing treatment for cancer or diseases that result in chronic anemia. Approximately 50% to 65% of open heart surgery patients receive blood transfusions.

In 2008, sales of transfusion management products in the countries of France, Germany, Italy, Spain, and the United Kingdom (U.K.) totaled approximately $245.5 million; over the forecast period covered by this report, sales of these products are expected to increase at a compound annual rate of 3.8%, reaching an estimated $296.3 million in the year 2013.

This dynamic, new report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the area of transfusion management. Market segments covered by this report include blood salvage equipment and disposables and plasma volume expanders. This report also includes an update on the progress of clinical development of blood substitutes, or intravascular oxygen carriers, as well as an analysis of critical care in Europe and a discussion of the healthcare structures and regulations in France, Germany, Italy, Spain, and the U.K.

TABLE OF CONTENTS:
EXECTIVE SUMMARY

i. Clinical Overview
ii. European Markets for Transfusion Management Products
	a. Blood Salvage/Autotransfusion Systems
	b. Blood Substitutes/Intravascular Oxygen Carriers
	c. Plasma Volume Expanders
iii. Market Analysis
iv. Methodology

Exhibit ES-1: Europe, Transfusion Management Products, Combined Market Forecast, 2008-2013

1. EUROPEAN HEALTHCARE MARKETS

1.1 The European Union
	1.1.1 A Common Currency
	1.1.2 Regulatory Policies
	1.1.3 Reimbursement
	1.1.4 Healthcare Spending
1.2 Selected European National Healthcare Profiles
	1.2.1 France
		1.2.1.1 Healthcare Organization and Reform
		1.2.1.2 Hospital Services
		1.2.1.3 Medical Device Reimbursement
	1.2.2 Germany
		1.2.2.1 Healthcare Organization and Reform
		1.2.2.2 Hospital Services
		1.2.2.3 Medical Device Reimbursement
	1.2.3 Italy
		1.2.3.1 Healthcare Organization and Reform
		1.2.3.2 Hospital Services
		1.2.3.3 Medical Device Reimbursement
	1.2.4 Spain
		1.2.4.1 Healthcare Organization and Reform
		1.2.4.2 Hospital Services
		1.2.4.3 Medical Device Reimbursement
	1.2.5 United Kingdom
		1.2.5.1 Healthcare Organization and Reform
		1.2.5.2 Hospital Services
		1.2.5.3 Medical Device Reimbursement

Exhibit 1-1: European Union, Medical Devices Risk Classification System
Exhibit 1-2: Europe, Population Statistics Comparison for the Years 2008 and 2018
Exhibit 1-3: France, Selected National Healthcare Statistics
Exhibit 1-4: Germany, Selected National Healthcare Statistics
Exhibit 1-5: Italy, Selected National Healthcare Statistics
Exhibit 1-6: Spain, Selected National Healthcare Statistics
Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics

2. OVERVIEW OF THE CRITICAL CARE ENVIRONMENT

2.1 Conditions Treated in the Critical Care Unit
2.2 Critical Care Unit Staffing
	2.2.1 Intensivists
	2.2.2 Nurses and Other Allied Healthcare Professionals
2.3 Critical Care Units, by Size and Type
2.4 Equipment and Products Used in the Critical Care Setting
	2.4.1 Invasive and Noninvasive Equipment and Products
	2.4.2 Transport Equipment and Products
2.5 Critical Access Hospital Designation
2.6 Issues Affecting Critical Care Delivery
	2.6.1 Patient Demographics
	2.6.2 Managed Care
	2.6.3 Healthcare Personnel Shortages
	2.6.4 Trends in Critical Care Product Purchasing

Exhibit 2-1: 2006, Number of Anesthetists/Intensivists in Selected European Countries
Exhibit 2-2: Selected Critical Care Nursing and Allied Healthcare Responsibilities
Exhibit 2-3: 2006, Number of Emergency Rooms and Beds in Selected European Countries
Exhibit 2-4: 2006, Total Equipped Positions, by Type of Intensive Care Unit and Facility in Selected European Countries
Exhibit 2-5: 2006, France, Total Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-6: 2006, Germany, Total Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-7: 2006, Italy, Total Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-8: 2006, Spain, Total Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-9: 2006, United Kingdom, Total Equipped Positions, by Type of Intensive Care Unit and Facility

3. EUROPEAN MARKETS FOR TRANSFUSION MANAGEMENT PRODUCTS

3.1 Clinical Overview
	3.1.1 Banked Blood Supply
	3.1.2 Allogeneic and Autologous Blood Transfusions
	3.1.3 Blood Bank Product Safety and Testing Protocols
	3.1.4 Blood Components
	3.1.5 Incidence of Blood Transfusions
3.2 Blood Salvage/Autotransfusion Systems
	3.2.1 Applications
	3.2.2 Costs
	3.2.3 Risks
	3.2.4 Intraoperative and Postoperative Blood Salvage
	3.2.5 Market Forecast
	3.2.6 Competitive Analysis
3.3 Blood Substitutes/Intravascular Oxygen Carriers
3.4 Plasma Volume Expanders
	3.4.1 Colloid Solutions
		3.4.1.1 Human Serum Albumin
		3.4.1.2 Plasma Protein Fraction
		3.4.1.3 Hydroxyethyl Starch
		3.4.1.4 Dextran
		3.4.1.5 Gelatin
	3.4.2 Crystalloid Solutions
		3.4.2.1 Normal Saline
		3.4.2.2 Dextrose Solutions
		3.4.2.3 Hartmann's Solution
	3.4.3 Market Forecast
	3.4.4 Competitive Analysis
3.5 Combined Market Forecast

Exhibit 3-1: 2009, Selected Blood Salvage/Autotransfusion Systems
Exhibit 3-2: Europe, Blood Salvage Systems, Combined Market Forecast, 2008-2013
Exhibit 3-3: Europe, Blood Salvage Equipment, Market Forecast, 2008-2013
Exhibit 3-4: Europe, Blood Salvage Disposables, Market Forecast, 2008-2013
Exhibit 3-5: 2008, Blood Salvage Products Market, Share by Supplier
Exhibit 3-6: 2009, Types of Plasma Volume Expanders and Their Indications
Exhibit 3-7: 2009, Selected Plasma Volume Expanders
Exhibit 3-8: Europe, Plasma Volume Expanders, Combined Market Forecast, 2008-2013
Exhibit 3-9: Europe, Colloids, Market Forecast, 2008-2013
Exhibit 3-10: Europe, Crystalloids, Market Forecast, 2008-2013
Exhibit 3-11: Europe, Transfusion Management Products, Combined Market Forecast, 2008-2013

4. COMPANY PROFILES

4.1 Baxter International, Inc.
4.2 B. Braun Melsungen AG
4.3 CSL Behring LLC/CSL LTD
4.4 Fresenius SE
4.5 Grifols SA
4.6 Haemonetics Corporation
4.7 Oxygen Biotherapeutics, Inc.
4.8 Sangart, Inc.
4.9 Sorin SPA
4.10 Talecris Biotherapeutics, Inc.

APPENDIX: COMPANY LISTING


COMPANIES COVERED:

  1. Baxter International, Inc.
  2. B. Braun Melsungen AG
  3. CSL Behring LLC/CSL LTD
  4. Fresenius SE
  5. Grifols SA
  6. Haemonetics Corporation
  7. Oxygen Biotherapeutics, Inc.
  8. Sangart, Inc.
  9. Sorin SPA
  10. Talecris Biotherapeutics, Inc.
Contact Us

Need help finding medtech research? Let us help you!